This document specifies information model of representation for quality control of Chinese patent drugs by defining a set of domain constraints of sanctioned characteristics each composed of a relationship and an applicable information model in order to represent the quality control of manufacturing process of Chinese materia medica. It is applicable to the quality supervision and management of manufacturing process of Chinese materia medica. Japanese KAMPO medicine is out of the scope.
IN_DEVELOPMENT
ISO/TS 5044
60.00
Standard under publication
Feb 7, 2023
Only informative sections of projects are publicly available. To view the full content, you will need to members of the committee. If you are a member, please log in to your account by clicking on the "Log in" button.